SCHEMBL21069258

SCHEMBL21069258

OCCOC1(O)CCCC1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28010659 0.77 SLC6A4 (0.33)
SCHEMBL10828416 0.73
SCHEMBL6843844 0.72
SCHEMBL2502222 0.68 NR5A2 (0.37)
SCHEMBL911582 0.67 SLC6A3 (0.33)
SCHEMBL28396629 0.67
SCHEMBL9152767 0.66 SLC6A3 (0.38)
SCHEMBL5516435 0.64
SCHEMBL15512931 0.63 MEN1 (0.38)
SCHEMBL16052969 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190194213-A1 NEW USE OF TRIAZOLO(4,5 D)PYRIMIDINE DERIVATIVES FOR PREVENTION AND TREATMENT OF BACTERIAL INFECTION Université de Liège (BE) 2019-06-27 US claimed
CN-109689061-B Novel use of triazolo (4, 5-d) pyrimidine derivatives for the prevention and treatment of bacterial infections 列日大学 2023-03-31 CN disclosed
US-20190194213-A1 NEW USE OF TRIAZOLO(4,5 D)PYRIMIDINE DERIVATIVES FOR PREVENTION AND TREATMENT OF BACTERIAL INFECTION Université de Liège (BE) 2019-06-27 US disclosed